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Abstract
The activity-regulated cytoskeleton-associated (Arc) protein controls synaptic strength by facilitating AMPA
receptor (AMPAR) endocytosis. Here we demonstrate that Arc targets AMPAR to be internalized through a direct
interaction with the clathrin-adaptor protein 2 (AP-2). We show that Arc overexpression in dissociated hippocam-
pal neurons obtained from C57BL/6 mouse reduces the density of AMPAR GluA1 subunits at the cell surface and
reduces the amplitude and rectification of AMPAR-mediated miniature-EPSCs (mEPSCs). Mutations of Arc, that
prevent the AP-2 interaction reduce Arc-mediated endocytosis of GluA1 and abolish the reduction in AMPAR-
mediated mEPSC amplitude and rectification. Depletion of the AP-2 subunit 2 blocks the Arc-mediated
reduction in mEPSC amplitude, an effect that is restored by reintroducing 2. The Arc–AP-2 interaction plays an
important role in homeostatic synaptic scaling as the Arc-dependent decrease in mEPSC amplitude, induced by
a chronic increase in neuronal activity, is inhibited by AP-2 depletion. These data provide a mechanism to explain
how activity-dependent expression of Arc decisively controls the fate of AMPAR at the cell surface and modulates
synaptic strength, via the direct interaction with the endocytic clathrin adaptor AP-2.
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Introduction
Activity-dependent long-lasting alterations in glutamatergic
synaptic strength are the molecular substrate thought to un-
derlie learning and memory. The establishment and mainte-
nance of changes in synaptic strength is dependent on
trafficking of AMPA receptors (AMPAR) at the postsynaptic
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of synaptic plasticity and may provide a novel target for therapeutic intervention.
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membrane (Ehlers, 2000; Newpher and Ehlers, 2008), together
with changes in protein synthesis (Buffington et al., 2014). In
recent years, several neuron specific immediate early genes
(IEGs) that are rapidly induced in response to neuronal activity
have been described (Flavell and Greenberg, 2008), including
activity-regulated cytoskeleton-associated (Arc) protein, also
named activity-regulated gene of 3.1 kb (Arg3.1). Following
neuronal activation, Arc mRNA is rapidly trafficked to postsyn-
aptic dendritic sites and locally translated (Lyford et al., 1995;
Steward et al., 1998). A rapid increase in Arc protein expression
regulates synaptic strength, mainly by enhancing the endocy-
tosis of AMPAR at postsynaptic sites (Rial Verde et al., 2006;
Shepherd et al., 2006; Waung et al., 2008; Mabb et al., 2014).
A number of studies have shown that Arc regulates several
forms of synaptic plasticity, including homeostatic scaling
(Shepherd et al., 2006; Corrêa et al., 2012; Mabb et al., 2014)
and metabotropic glutamate receptor-dependent long-term
depression (Waung et al., 2008; Jakkamsetti et al., 2013; Mabb
et al., 2014). Arc is also required for inverse synaptic tagging. In
this process, strong neuronal stimulation induces Arc expres-
sion, which binds to inactive CaMKII (Okuno et al., 2012). The
Arc/CaMKII complex then operates as a sensor to identify
and induce endocytosis of AMPAR at weaker synapses thus
increasing the difference between activated and non-activated
synapses. Together, these findings demonstrate a pivotal role
for Arc in regulating synapse strength after neuronal activation.
The clathrin-mediated endocytic (CME) pathway has
been the subject of intensive studies in the past decades.
Therefore, the molecular machinery involved in the se-
quential events linking the selection of the endocytic
cargo and assembly of the clathrin scaffold leading to
membrane bending and scission of the newly formed
clathrin-coated vesicles has been precisely described
(Saheki and De Camilli, 2012; Canagarajah et al., 2013;
Kirchhausen et al., 2014). The clathrin-adaptor protein 2
(AP-2), which is a heterotetramer composed of two large
(/2) and two small (2/2) subunits, plays an essential
role in the formation of endocytic clathrin-coated vesicles
(CCV). To initiate the clathrin-coat assembly the AP-2
complex first binds to the transmembrane cargo that is to
be internalized and subsequently binds and connects
clathrin to the plasma membrane (Saheki and De Camilli,
2012; Traub and Bonifacino, 2013; Kirchhausen et al.,
2014). The sequential events observed during clathrin-
mediated endocytosis are conserved across different eu-
karyotic cell types including neurons (Saheki and De
Camilli, 2012). In hippocampal neurons, the cytosolic tail
of the AMPAR subunit 2 (GluA2) directly binds to AP-2
(Kastning et al., 2007) and disruption of the AMPAR–AP-2
interaction compromises the Arc-mediated facilitation of
AMPAR endocytosis (Rial Verde et al., 2006).
Here we show that Arc directly binds to AP-2 and that
this interaction is required for Arc-mediated endocytosis
of GluA1 subunits and consequent changes in synaptic
transmission. Under basal conditions, overexpression of
Arc-wild-type (Arc-WT) reduces the amplitude and recti-
fication of AMPAR-mediated miniature EPSCs (mEPSCs),
whereas Arc proteins bearing mutations in the AP-2 bind-
ing site, have little or no effect. Furthermore, depletion of
AP-2 blocks the Arc-mediated reduction in mEPSC am-
plitude, an effect that is rescued when AP-2 expression is
restored. The interaction between Arc and AP-2 is also
important in homeostatic synaptic scaling, as depletion of
AP-2 significantly reduces the Arc-dependent decrease in
AMPAR mEPSC amplitude induced by increased neuro-
nal activity. The discovery that the direct interaction be-
tween Arc and AP-2 facilitates rapid and sustained
AMPAR endocytosis provides the mechanistic link by
which constitutive endocytosis can be regulated by
changes in activity in neurons. These findings further
consolidate the strategic role of Arc in facilitating activity-
dependent endocytosis of AMPAR in synaptic plasticity.
Materials and Methods
Animals used in this study were treated in accordance
with UK Animal (Scientific Procedures) Act 1986 legisla-
tion and under the appropriate national and local ethical
approval. Sample size was calculated using variance from
previous experiments to indicate power, with statistical
significance set at 95%. Replication values are incorpo-
rated in the figures, where appropriate.
Immunoprecipitation and immunoblot analysis
To identify new proteins that interact with endogenous
Arc/Arg3.1 proteins hippocampi from 10-week-old male
C57BL/6 mice were used. To extract the hippocampi,
animals were deeply anaesthetized and the brains were
rapidly removed and placed in ice-cold artificial CSF con-
sisting of the following (mM): 124 NaCl, 3 KCl, 26 NaHCO3,
1.25 NaH2PO4, 2 CaCl2, 1 MgSO4, and 10 D-glucose
(bubbled with 95% O2 and 5% CO2). Hippocampi were
then isolated from the surrounding tissue and cut into
small pieces using a dissecting microscope (Leica LED
1000). The tissue was then homogenized in Eppendorf
Scientific tubes with a pellet pestle in ice-cold solution
composed of: 10 mM HEPES, 0.32 M sucrose, and pro-
tease inhibitor cocktail (Roche) and rotated for 1 h at 4°C.
Homogenate was centrifuged at 13,000  g for 15 min,
the supernatant collected and protein levels determined
(BCA protein assay kit, Thermo Scientific). Five-hundred
micrograms of protein, making 500 l of final volume, was
incubated with 1 g of rabbit polyclonal anti-Arc antibody
(Synaptic Systems, 156-003) and 15 l of prewashed
protein G agarose beads (Upstate-Millipore, 16-266) and
rotated for 3 h at 4°C. As a negative control, 500 g of
protein was incubated with 15 l with protein G agarose
beads only. Arc-immunoprecipitation (IP) and negative
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control samples were centrifuged at 7000  g for 30 s to
precipitate the beads. The supernatant was removed and
the beads washed three times with lysis buffer containing
1 mM EDTA, 1 M Tris-HCl, pH 7.5, 1% Triton X-100, 1 mM
sodium orthovanadate, 50 mM sodium fluoride, sodium
pyrophosphate, 0.27 M sucrose, 20% NaN3, and protease
inhibitor cocktail (Roche). Proteins were eluted from the
beads with 20 l of 5 loading buffer, and the total
amount of the eluted protein from the beads were loaded
into a 10% SDS-PAGE gels and separated for 1.5 cm
using electrophoresis system.
To further confirm the endogenous interaction between
Arc and AP-2 in the hippocampus, we used the co-IP
experimental conditions described above. Eluted IP
proteins, as well as inputs, were separated in 10% SDS-
PAGE gels, transferred into membrane using electropho-
resis system, and blots were incubated overnight with
primary antibodies: rabbit anti-Arc/Arg3.1 (1:1000 dilution),
mouse anti--adaptin1/2 (1:1000 dilution, sc-17771), and
goat anti-clathrin HC (1:1000 dilution, sc-6579). Normal
Rabbit IgG (1:1000; R&D Systems, AB-105-C) was used as
negative control for the IP experiments. Appropriate second-
ary antibodies were used to detect proteins levels.
Proteomics and MS analysis
Each gel lane (Arc-IP and control) were cut in small
pieces and subjected to in-gel tryptic digestion using a
ProGest automated digestion unit (Digilab). The resulting
peptides were fractionated using a Dionex Ultimate 3000
nanoHPLC system. Briefly, peptides in 1% (v/v) formic
acid were injected onto an Acclaim PepMap C18 nano-
trap column (Dionex). After washing with 0.5% (v/v) ace-
tonitrile 0.1% (v/v) formic acid peptides were resolved on
a 250 mm  75 m Acclaim PepMap C18 reverse phase
analytical column (Dionex) over a 120 min organic gradi-
ent with a flow rate of 300 nl min1. Peptides were ionized
by nano-electrospray ionization at 2.3 kV using a stainless
steel emitter with an internal diameter of 30 m (Proxeon).
Tandem mass spectrometry analysis was carried out on a
LTQ-Orbitrap Velos mass spectrometer (Thermo Scien-
tific). The Orbitrap was set to analyze the survey scans at
60,000 resolution and the top 20 ions in each duty cycle
selected for MS/MS in the LTQ linear ion trap. Data were
acquired using the Xcalibar v2.1 software (Thermo Scien-
tific). The raw data files were processed and quantified
using Proteome Discoverer software v1.2 (Thermo Scien-
tific) with searches performed against the UniProt rat
database by using the SEQUEST algorithm with the fol-
lowing criteria; peptide tolerance 10 ppm, trypsin as the
enzyme, carbamidomethylation of cysteine as a fixed
modification and oxidation of methionine as a variable
modification. The reverse database search option was
enabled and all data were filtered to satisfy false discovery
rate of 5%. Only hits from the Arc-co-IPs were consid-
ered for further characterization. The proteomics experi-
ments were repeated twice.
Hippocampal cell culture and transfection
Hippocampal neuronal cultures were prepared from
either male or female postnatal day 0 pups from C57BL/6
wild-type mice as described previously (Canal et al.,
2011). Briefly, hippocampi were extracted from the brain
at 4°C, subject to digestion with trypsin (Sigma-Aldrich),
and mechanically dissociated with DNAse (Sigma-Aldrich).
Cells were plated onto 22 mm glass coverslips coated with
poly-L-lysine hydrobromide (0.5 mg/ml, Sigma-Aldrich). The
plating medium consisted of Neurobasal-A medium (Invitro-
gen) supplemented with Gentamycin (ForMedium), L-Gluta-
mine (ForMedium), 2% B27 (Invitrogen), and 5% horse se-
rum (Invitrogen). The following day, the plating medium was
changed for horse serum-free feeding medium. Cultures
were maintained at 37°C and 5% CO2 in a humidified incu-
bator. For immunocytochemistry and patch-clamp record-
ings, hippocampal cultured neurons were used at 14–16
days in vitro (DIV) and transfection were performed using
Lipofectamine 2000 (Life Technologies). For the patch-
clamp recordings, cells expressing Arc cDNAs were used
15–22 h after transfection and cells expressing shRNAs
were transfected at 6–7 DIV and recorded at 14–16 DIV.
Cell lineages culture and transfection
Human neuroglioma 4 (H4) cells obtained from the
American Type Culture Collection were cultured in DMEM
(Life Technologies), supplemented with 100 U of penicil-
lin/ml, 0.1 mg of streptomycin/ml, and 10% (vol/vol) fetal
bovine serum, and then transiently transfected using Li-
pofectamine 2000 (Life Technologies). Neuroblastoma 
Spinal Cord (NSC) hybrid mouse cell lines (Cashman
et al., 1992) cultured in supplemented DMEM were trans-
fect with negative control (n.c.) shRNA, 2-shRNA2, 2-
shRNA3 constructs using calcium phosphate as
previously described (Canal et al., 2011). After 72–96 h of
transfection, cells were washed, lysed in the presence of
protease inhibitor cocktail (Roche), and 10 g of protein
were loaded onto a 10% acrylamide gel. Proteins were
separated using an SDS-PAGE system and transferred
onto Hydrobond-ECL membrane (GE Healthcare). Mem-
branes were incubated overnight with primary specific
mouse anti-AP-50 2 subunit antibody (1:500 dilution; BD
610350), and GAPDH (1:1000 dilution; Abcam ab8245 for
Fig. 6) or affinity purified rabbit polyclonal anti-GAPDH
antibody (1:1000 dilution; Sigma-Aldrich G9545, for Fig.
3). The membranes were incubated with appropriate
HRP-linked secondary antibodies anti-Mouse IgG (Cell
Signaling Technologies, 7076), anti-Mouse IgG (NA931V,
GE Healthcare) or anti-rabbit IgG (NA934V, GE Health-
care) incubated for 1 h at room temperature and blots
developed using ECL reagents.
Recombinant DNA constructs
Full-length mouse Arc cDNA (NM_018790.3) in pCMV-
SPORT7 vector was purchased from Open Biosystems
and used as a template to generate the Arc constructs.
The pGFP-Arc plasmid was generated by cloning the Arc
full-length sequence as an EcoRI/SalI fragment into the
pEGFP-C2 vector (Clontech). Site-directed mutagenesis
(QuickChange II kit, Qiagen) was used to mutate the
tryptophan 197 to alanine in the pEGFP-Arc(WT) construct.
To generate constructs encoding Arc195-199A, a syn-
thetic cDNA sequence was obtained from GenScript, en-
coding the mouse Arc residues 1 to 700, in which codons
to residues 195–199 (residues QSWGP) of the original Arc
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sequence were replaced by codons to alanine (QSWGP/
AAAAA). The Arc195-199A mutant sequence was then
used to replace the corresponding sequence in pGFP-
ArcWT, using EcoRI and a naturally occurring BglII (nt
647-652) restriction sites. This generated the pGFP-
Arc(W197A) and the pGFP-Arc(195-199A) plasmids, respec-
tively. The plasmids encoding untagged Arc and Arc
fused to mCherry (WT and mutants) were obtained by
inserting the Arc cDNAs from pEGFP plasmids as EcoRI/
SalI fragments into the pCIneo (Promega) or the
pmCherry-C2 vectors (Clontech), respectively. To express
Arc and Arc mutants in Escherichia coli the full-length Arc
(WT), Arc 1-194 and Arc 1-199 sequences were amplified
by PCR with specific primers and cloned into the pET28a
vector using EcoRI and SalI restriction sites. The resulting
plasmids encode Arc fused to a hexahistidine tag at the
N-terminus. To express GST-Arc(WT), GST-Arc(195-199A),
and GST-Arc(W197A) fusion proteins in E. coli, the Arc
coding sequences in pEGFP-C2 were subcloned into
pGEX5.1 (GE Healthcare) as EcoRI/SalI inserts. The
pcDNA3.1-2-mCherry vector was used to express 2-
adaptin in rescue experiments. This construct was gen-
erated using a two-step cloning strategy. Firstly, cDNA
encoding mouse 2 was amplified from pGADT7-2 (Guo
et al., 2013) and used to replace the Leucine Zipper (LZ)
sequence, in a pcDNA3.1-based plasmid consisting of a
LZ sequence followed by a linker and the C-terminal (VC:
159-239) fragment of Venus YFP, provided by Dr Stephen
Michnick (MacDonald et al., 2006). This construct was
subsequently used to replace the VC sequence by
the mCherry sequence, thus generating pcDNA3.1-2-
mCherry. To obtain the GFP-tagged Dynamin2 (WT) con-
struct, the open reading frame of dynamin 2 was cloned
into pEGFP-N1 as a HindIII and EcoRI insert. The
pEGFP-C3 based plasmid encoding GFP-Triad3A was
previously described (Mabb et al., 2014). All open reading
frames were verified by nucleotide sequence analysis.
Recombinant protein expression and GST pull-down
assays
The four subunits of rat AP-2 complex comprising
residues 1–621 from C adaptin (-trunk) fused to
glutathione-S-transferase (GST) at the N-terminus, resi-
dues 1–591 from 2 adaptin fused to a hexahistidine tag
at the C-terminus, and the full-length 2 and 2 adaptin;
(hereafter referred to as AP2 core) were coexpressed in E.
coli BL21 Rosetta (DE3) cells from a pST39 vector (Shef-
field et al., 1999) under the control of T7 promoter with
each gene having its own ribosome-binding site (Chaud-
huri et al., 2007; Chaudhuri et al., 2009). For GST-AP-2
core expression, bacteria were grown at 37°C to an op-
tical density at 600 nm of 0.8. Then cultures were shifted
to 18˚C and the expression was induced with 0.2 mM IPTG
(isopropyl--D-thiogalactopyranoside) for 12 h. The cell
pellet was resuspended in ice-cold lysis buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 10% glycerol, 2 mM EDTA,
10 mM DTT), supplemented with 500 g/ml lysozyme and
1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydro-
chloride and disrupted by sonication. Insoluble material
was removed by centrifugation and the AP-2 core in the
supernatant was purified using a His-trap column (GE
Healthcare). Briefly, the AP-2 core complex was bound to
the His-trap column via the 6xHis-2 subunit, repeatedly
washed with Tris-buffer solution (TBS) composed of 50
mM Tris-HCl, pH 7.4, 500 mM NaCl supplemented with 30
mM of imidazol (Sigma-Aldrich) and eluted with TBS with
0.25 M of imidazol. Recombinant GST (pGEX plasmid),
GST-Arc(WT), GST-Arc(195-199A), GST-Arc(W197A), and 6XHis-Arc
(wild-type and truncated) were also expressed in E. coli BL21
Rosetta (DE3) cells at 30°C with 0.5 mM IPTG. The pellet was
resuspended in ice-cold lysis buffer, sonicated and after cen-
trifugation, and supernatant containing the soluble proteins
was used for pull-down assays.
Recombinant GST-AP-2 core or GST alone was immo-
bilized onto glutathione-sepharose beads (GE Healthcare)
overnight at 4°C. Beads were washed with ice-cold TBS
containing 5% of Triton X-100 (Sigma-Aldrich) and incu-
bated with either His-trap column purified 6xHis-Arc or
total cell lysates of E. coli expressing 6x-His-Arc proteins
for 3 h. After four washes with ice-cold TBS plus 5% of
Triton X-100 the beads were resuspended in sample buf-
fer (SDS 4%, Tris-HCl 160 mM, pH 6.8, glycerol 20%, DTT
100 mM, and bromophenol blue 0.005%), boiled, and
proteins were separated by SDS-PAGE and transferred
onto a nitrocellulose membrane (GE Healthcare), which
were then blocked for 1 h with PBS, 0.1% Tween 20, and
5% milk powder. Primary mouse monoclonal anti-His tag
antibody (1:1000 dilution, Sigma-Aldrich H1029) were
added in PBS, 1% BSA for 1 h. After three washes with
PBS-T, the membranes were incubated with HRP-
conjugated secondary antibody for 1 h and washed again.
Recombinant GST, GST-Arc(WT), GST-Arc(W197A), and
GST-Arc(195-199A) were immobilized onto glutathione-
sepharose beads overnight at 4°C. Beads were incubated
with either total brain tissue lysate, obtained as described
earlier for hippocampi lysate, or total lysates of HEK293
cells expressing either dynamin 2-GFP or GFP-Triad3A
for 1 h at 4°C on ice. The beads were centrifuged at 100
 g, washed three times with lysis buffer, supplemented
with 1% (v/v) Triton X-100, and subsequently resus-
pended in SDS-PAGE sample buffer. Beads were boiled,
and proteins were resolved by SDS-PAGE and analyzed
by immunoblot as described above using mouse mono-
clonal anti-AP-50 2 subunit (1:500 dilution; BD 611350),
anti--adaptin1/2 (1:1000 dilution, sc-17771), and rabbit
polyclonal anti-GFP antibodies. Proteins were detected
using ECL reagents.
Immunocytochemistry
H4 neuroglioma cells (ATCC) were transfected with
plasmids encoding a myc-tag at the N-terminus of GluA1
(Leuschner and Hoch, 1999) together with plasmids en-
coding either mCherry, mCherry-Arc-WT, or mCherry-
Arc(W197A). Twenty hours after transfection, cells were
fixed using 4% paraformaldehyde, pH 7.4, in 0.1 M PBS
for 15 min at room temperature and incubated for 30 min
at 37°C in blocking solution (0.2% pork skin gelatin) in
PBS. Cells were then incubated with hybridoma culture
supernatant (9E10) containing mouse monoclonal anti-
myc antibody (at 1:10 dilution). Cells were washed with
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PBS and incubated with AlexaFluor 488 anti-mouse IgG
(1:1000; Life Technologies) diluted in blocking solution.
Cells were then permeabilized for 10 min with 0.1% Triton
X-100 in PBS and incubated again with rabbit polyclonal
anti-myc antibody (a gift from R. Hegde, MRC, LMB,
Cambridge, UK) for 30 min at 37°C in blocking solution.
This was followed by incubation with AlexaFluor 647 anti-
rabbit IgG (1:1000; Life Technologies) diluted in blocking
solution. Coverslips were mounted on glass slides, and
cells were imaged using a Zeiss LSM 780 confocal micro-
scope.
Biotinylation assays
To analyze the amount of surface and intracellular
GluA1 and GluA2 proteins H4 neuroglioma cells were
transfected and subject to a biotinylation protocol previ-
ously described (Eales et al., 2014). Briefly, the same
amount of H4 cells were seeded in each well of 6-well
dishes (3  105 cells/well) and then transfected with 2 g
of plasmids encoding N-terminus myc-tagged GluA1 or
GluA2 (Leuschner and Hoch, 1999) in combination with 2
g of pCIneo, pCIneo-Arc(WT), or pCIneo-Arc(W197A) using
Lipofectamine 2000. After 24 h, the cells were washed
and incubated with 1 ml of 0.25 mg/ml of EZ-Link Sulfo-
NHS-SS-Biotin (Thermo Scientific) in ice-cold PBS for
15 min at 4°C. The cells were washed twice with ice-cold
PBS, with 3 ml of NH4Cl 50 mM for 5 min (4°C on a
shaker), and then once more with PBS. After washing,
cells were lysed with 100 l of lysis buffer (described
above) containing protease inhibitors, rotated for 1 h at
4°C, centrifuged at 20,000  g for 10 min at 4°C and the
supernatants collected. The protein concentration was
assayed using the BioRad Protein Assay Reagent and
equal amounts were incubated with prewashed 30 l of
NeutrAvidin Ultra-link Resin (Life Technologies) for 3 h on
a wheel at 4°C. The beads were washed three times with
lysis buffer, and the proteins eluted from the beads using
20 l of 5 loading buffer. Proteins were loaded on an 8%
SDS-PAGE gel. The input represents 1% of the total
protein incubated with the beads. The Western blot was
performed as described above.
Lentiviruses production
A lentiviral transduction system was used to achieve effi-
cient delivery of specific microRNA-adapted shRNA se-
quences into neurons. Double-stranded oligonucleotides
encoding shRNAs targeting the mouse 2 subunit (shRNA1:
tgctgtgaattgccctccatatggttgttttggccactgactgacaaccatatagg
gcaattca/cctgtgaattgccctatatggttgtcagtcagtggccaaaacaacc
atatggagggcaattcac; shRNA2: tgctgcatattggtactctattgcctg
ttttggccactgactgacaggcaatagtaccaatatg/cctgcatattggtag
tattgcctgtcagtcagtggccaaaacaggcaatagagtaccaatatgc;
shRNA3: tgctgatctgcaggacattgcttcacgttttggccactgactga
cgtgaagcagtcctgcagat/cctgatagattcctatcaggctggtcag
tcagtggccaaaaccagcctgagttaggaatctatc) were cloned into
the linearized pcDNA6.2-GW/EmGFP-miR vector (Invitro-
gen). The sequences were designed using the “BLOCK-iT
RNAi Designer” software from Invitrogen to identify se-
quences specific for mouse 2 that are not predicted to
knockdown expression of any other genes. In addition, the
sequences have 100% homology to the target sequence
and result in target cleavage. The vector contains flanking
sequences allowing the shRNAs to be expressed and pro-
cessed analogous to endogenous miRNAs and not shRNAs.
This arrangement enables the expression of the shRNA cas-
sette from an RNA polymerase II promoter. In addition,
emGFP is expressed iso-cistronically from the same pro-
moter to allow the precise identification of the transduced
cells. As a negative control, the plasmid pcDNA6.2-GW/
EmGFP-miR-neg control (Invitrogen) was used. This plas-
mid contains an insert that forms a hairpin structure, which is
processed into mature shRNA, but is predicted not to target
any known vertebrate gene (gaaatgtactgcgcgtggagacgttttg-
gccactgactgacgtctccacgcagtacattt). The above expression
cassettes were transferred into the lentiviral expression vec-
tor pLenti6/V5-DEST (Invitrogen) by gateway cloning. Lenti-
viruses were produced according to the instructions of the
manufacturer (Invitrogen; Block-It HiPerform Lentiviral Pol II
RNAi Expression system with emGFP; K4934). Lentivirus
particles were collected from the culture supernatants, pu-
rified, and concentrated by incubation with 8.5% PEG 6000
and 0.4mM NaCl for 1.5 h at 4°C, followed by centrifugation
at 7000  g for 10 min (4°C). Pellets were re-dissolved in
neurobasal medium.
Bicuculline incubation
To induce a chronic increase in neuronal activity, hip-
pocampal cultures were incubated with bicuculline (40
M, Sigma-Aldrich) for 48 h prior to experimental work.
Electrophysiological recordings and analysis of
AMPAR-mediated mEPSCs
mEPSCs were recorded from 15 to 18 DIV cultured
pyramidal hippocampal neurons (Mabb et al., 2014). A
coverslip was transferred to the recording chamber and
perfused at a constant flow rate of (2–3 min1) with a
recording solution composed of (mM): 127 NaCl, 1.9 KCl,
1 MgCl2, 2 CaCl2, 1.3 KH2PO4, 26 NaHCO3, 10 D-glucose,
pH 7.4 (when bubbled with 95% O2 and 5% CO2, 300
mOsm) at 28–30°C. To isolate AMPA receptor mediated
mEPSCs, tetrodotoxin (1 M, Tocris Bioscience), picro-
toxin (50 M, Sigma-Aldrich) and L-689,560 (5 M, Tocris
Bioscience) were present in the recording solution. Cul-
tured neurons were visualized using IR-DIC optics with an
Olympus BX51W1 microscope and Hitachi CCD camera
(Scientifica). Whole-cell patch-clamp recordings were
made from transfected (identified by fluorescence at 488
nm) and neighboring untransfected pyramidal neurons
with patch pipettes (5–8 M) made from thick-walled
borosilicate glass (Harvard Apparatus) filled with the follow-
ing (mM): 135 potassium gluconate, 7 NaCl, 10 HEPES, 0.5
EGTA, 10 phosphocreatine, 2 MgATP, 0.3 NaGTP, pH 7.2,
290 mOsm. Recordings of mEPSCs were obtained at a
holding potential of75 mV using an Axon Multiclamp 700B
amplifier (Molecular Devices), filtered at 3 kHz and digitized
at 20 kHz (Digidata 1440A, Molecular Devices). For rectifi-
cation experiments, the intracellular solution contained the
following (mM): 135 CsCl, 10 HEPES, 10 EGTA, 2 Mg-ATP,
0.1 spermine, pH 7.2 with tetraethylammonium-0H, 285
mOsm. To calculate the rectification index, mEPSC record-
ings were made at holding potentials of 60 and 40 mV.
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Data acquisition was performed using pClamp 10 (Molecular
Devices).
Analysis of mEPSCs was performed using MiniAnalysis
software (SynaptoSoft). For most experiments, where the
holding potential was 75 mV, events were manually
analyzed and were accepted if they had an amplitude 6
pA and a faster rise than decay. For the rectification
experiments, where the holding potential was 60 and
40 mV and thus mEPSCs had a smaller amplitude,
events were accepted if they had an amplitude3 pA and
a waveform with a faster rise than decay. Cumulative
probability curves for mEPSC amplitude were con-
structed from 1000 to 2000 mEPSCs pooled from all
recordings, with the same number of mEPSCs (150) mea-
sured from each recording (Origin, Microcal). The interval
between events was measured using MiniAnalysis soft-
ware. To measure mEPSC kinetics, mEPSCs within indi-
vidual recordings were aligned on the half-amplitude of
their rise and averaged (50–100 mEPSCs were averaged
in each recording). The decay of the mean current from
each recording was fitted with a single exponential (max-
imum likelihood, MiniAnalysis or Microcal Origin). Rise
times were measured from mean currents as the time
required for the current to rise from 10% to 90% of peak
amplitude. The rectification index was calculated for each
recording (peak amplitude at 40 mV divided by peak
amplitude at 60 mV), and then the mean rectification
index was calculated for each experimental condition. For
each cell an average of 100–200 mEPSCs were analyzed.
Individual mEPSCs were aligned to 50% of the rise, av-
eraged and then the mean amplitude was measured from
the peak of this mEPSC waveform. Statistical significance
was measured using the Mann–Whitney test. Where pos-
sible, comparisons were made between transfected and
untransfected neighboring neurons in the same culture.
For each experimental condition, cells were recorded and
analyzed using hippocampal cultures from 4 to 5 different
preparations.
Statistical analysis
Data were analyzed using Prism (v5.04, GraphPad) and
Statistical Package for the Social Sciences 21 (IBM) soft-
ware. Mann–Whitney t tests, Kolmogorov–Smirnov test,
one-way ANOVA, and the corresponding post hoc tests
(Tukey or Dunn’s) were performed as appropriate.
Results
Arc interacts with the AP-2 complex in neurons
Arc has been shown to regulate glutamatergic synaptic
transmission by dynamically enhancing AMPAR endocy-
tosis in postsynaptic neurons (Shepherd et al., 2006;
Mabb et al., 2014). Given the importance of Arc in facili-
tating AMPAR endocytosis during synaptic transmission,
we speculated that it may play a decisive role in selecting
the cargo to be internalized. To test whether Arc interacts
with proteins of the CME machinery and whether Arc is
involved in selecting the cargo to be targeted for endo-
cytosis, we used the specific rabbit anti-Arc antibody to IP
endogenous Arc from adult C57BL6/J mice hippocampal
lysate combined with mass spectrometric analysis to
identify novel Arc binding partners. The control for the IP
was obtained by incubating hippocampal lysate protein
with the G agarose beads in the absence of Arc antibody.
The eluted proteins from both Arc-IP and control-IP sam-
ples were subjected to tandem mass spectrometry anal-
ysis. We only considered peptides present in the Arc-IPs
for further analysis and discarded unspecific peptides
present in both Arc- and control-IPs. Using this criteria we
identified different subunits of the AP-2 as endogenous
binding partners of Arc, including the two  adaptin iso-
forms:  also known as A (19 peptides and recovery of
22.83%; NP_031484) and 2, also known as C (11 pep-
tides and recovery of 12.37%; NP_031485), as well as 2
(11 peptides and recovery of 12.38%; NP_082191) and 2
(9 peptides and recovery of 20.79%; Q3TWV4). These
peptides were found independently in two experimental
repeats. We also found clathrin heavy chain (30 peptides
and recovery of 20%; NP_001003908), dynamin 1 (10
peptides and recovery of 10.57%; NP_034195), CamKII 
subunit (9 peptides and recovery of 20.48%, NP_031621),
and PSD95 (2 peptides and recovery 5.77%, NP_031890).
Importantly, PSD95, dynamin, and CamKII were previ-
ously shown to co-IP with Arc (Lyford et al., 1995; Chow-
dhury et al., 2006; Okuno et al., 2012). To further confirm
that Arc interacts with AP-2 endogenously, we immuno-
precipitated Arc protein from hippocampal lysate as
previously described and resolved the proteins using
SDS-PAGE. Immunoblot analysis confirmed that Arc co-
immunoprecipitates with the  subunit of the AP-2 com-
plex (Fig. 1A,B). We observed that clathrin heavy chain
also coimmunoprecipitates with Arc (Fig. 1B). This result
was expected as clathrin heavy chain is known to interact
with AP-2 (ter Haar et al., 2000; Edeling et al., 2006;
Knuehl et al., 2006). Together these findings suggest an
interaction between Arc and the proteins of the CME
machinery that are responsible for selecting the cargo to
be internalized. To test whether Arc directly interacts with
AP-2, we performed in vitro GST pull-down assays using
recombinant forms of Arc-WT and AP-2. Previous studies
used recombinant AP-2 “core” complexes to demon-
strate the direct interaction between AP-2 and the cyto-
solic tail of transmembrane cargo proteins (Höning et al.,
2005) or the HIV-1 accessory protein, Nef (Chaudhuri
et al., 2007; Lindwasser et al., 2008; Chaudhuri et al.,
2009). Therefore, we produced recombinant Arc-WT
fused to a hexahistidine tag and recombinant GST-tagged
AP-2 core, comprising the N-terminal “trunk” domains of
 and 2 subunits, plus the full-length 2 and 2 subunits
in E. coli. The recombinant AP-2 core complex and Arc
proteins were affinity purified (Fig. 1C) and used to show
that GST-tagged AP-2 core binds mouse Arc-WT, as
detected by immunoblot analysis (Fig. 1D). We then used
the same GST-pull-down approach to map the region of
Arc that interacts with AP-2. Our initial experiments dem-
onstrated that a C-terminal fragment of Arc comprising
residues 155–396 is sufficient to mediate the interaction
with AP-2. We then tested whether Arc mutants bearing
cumulative C-terminal deletions of 40 amino acid (aa) aa
residues would retain the capacity to bind AP-2. Using
this approach, we showed that the Arc C-terminus (resi-
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Figure 1. Arc directly interacts with the AP-2 complex. A, Arc coimmunoprecipitates with the  subunit of AP-2. Hippocampal lysate
was subjected to IP with an Arc antibody followed by immunoblot (IB) using an anti- adaptin antibody. Ten percent of the protein
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dues 200–396; Fig. 1E) is not essential for the Arc–AP-2
interaction, as truncated Arc missing these residues
(Arc1-199) was still able to interact with AP-2 (Fig. 1F).
Interestingly, deletion of a further 5 aa residues from the
C-terminus of Arc (Arc1-194) was sufficient to prevent
AP-2 binding (Fig. 1G). Binding of Arc recombinants to
GST alone was negligible, thus confirming the specificity
of the Arc–AP-2 interactions (Fig. 1D,F,G). Together,
these results demonstrated a direct and specific interac-
tion of Arc with the fully assembled AP-2 core complex.
Conservative tryptophan 197 mediates the Arc–AP-2
interaction
Our GST pull-down experiments indicate that the Arc
195QSWGP199 amino-acid sequence is required for its
interaction with AP-2. Therefore, we reasoned that a sin-
gle substitution of the highly conserved tryptophan in
position 197, may compromise the Arc–AP-2 interaction.
To test this, we performed in vitro protein-binding exper-
iments using immobilized recombinant GST-Arc(WT), GST-
Arc(195-199A), or GST-Arc(W197A) fusion proteins to pull-
down the endogenous  or 2 subunit of AP-2 from total
brain tissue lysates. We detected a robust interaction
between GST-Arc(WT) and either  or 2 (Fig. 2A; Table 1).
However this interaction was dramatically reduced when
GST-Arc(W197A), Arc(195-199A), or GST alone were used as
bait (Fig. 2A), indicating that W197 is crucially involved in
the interaction with AP-2. It was previously shown that Arc
interacts with dynamin-2 and that an internal deletion of
195–214 aa in Arc disrupt this interaction (Chowdhury
et al., 2006). To test the capacity of Arc(W197A) to interact
with dynamin, we performed similar in in vitro binding
analyses using immobilized GST-Arc(WT) or GST-Arc(W197A) to
pull-down GFP-dynamin-2 from HEK293 cell lysates. We
confirmed that Arc(WT) binds to dynamin, however, there is
a significant reduction in the interaction between
Arc(W197A) mutant and dynamin (Fig. 2B). In contrast, the
Arc mutants carrying alanine substitutions in the AP-2
binding motif still interact with the RING domain of the
ubiquitin ligase Triad3A/RNF216 (Fig. 2C), a protein re-
cently described to interact with Arc (Mabb et al., 2014).
Binding of Arc(W197A) and Arc(195-199A) to Triad3A indicates
that these alanine mutations do not cause gross confor-
mational changes in Arc which could prevent protein–
protein interaction.
Arc-mediated internalization of GluA1 requires the
Arc–AP-2 interaction
Arc(WT) overexpression in hippocampal neurons reduces
surface levels of AMPAR by selectively enhancing endo-
cytosis. We reasoned that Arc-mediated endocytosis of
AMPAR may be linked to its ability to interact with the
endocytic adaptor AP-2. To test this, we coexpressed
myc-GluA1 with either Arc(WT) or the Arc(W197A) mutant in
H4 human neuroglioma cells, and performed biotinylation
assay to monitor GluA1 and GluA2 surface expression
levels. As previously shown in hippocampal neurons
(Chowdhury et al., 2006), overexpression of Arc-WT in H4
cells resulted in a significant reduction of myc-GluA1
surface expression levels (Fig. 3A; Table 1). Importantly,
the reduction in myc-GluA1 surface expression was
blocked when Arc(W197A) mutant, that does not bind AP-2,
was coexpressed with myc-GluA1 (Fig. 3A). Interestingly
no changes in GluA2 surface expression were observed
when myc-GluA2 construct was coexpressed with either
Arc(WT) or the Arc(W197A) mutant (Fig. 3B), indicating that
the GluA2 subunit is potentially less sensitive to Arc than
GluA1 as previously suggested by Chowdhury et al.
(2006). To test whether Arc overexpression induces gen-
eral endocytosis of AP-2/clathrin cargo proteins, we ex-
amined the surface levels of EGF receptor (EGFR) in H4
cells expressing either Arc-WT or the Arc(W197A) mutant.
As expected, expression of Arc has no significant effect in
surface expression of EGFR (Fig. 3B). To confirm whether
Arc(W197A) mutant had an impact on the Arc-dependent
internalization of GluA1, we used the same experimental
condition described above to perform immunocytochem-
istry to label the amount of n terminus-myc-tagged GluA1
expressed at the surface. Confocal microscopy analyses
confirmed that Arc(WT) overexpression promotes a signif-
icant reduction of the GluA1 expression at the cell sur-
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lysate used for the IP was loaded in the input lane. B, Arc coimmunoprecipitates with clathrin in hippocampal lysate.
Hippocampal lysate was subjected to IP with a rabbit anti-Arc or a normal rabbit anti-IgG control antibodies followed by IB using
an anti- adaptin and anti-clathrin heavy chain antibodies. Ten percent of the protein lysate used for the IP was loaded in the
input lane. C, D, Pull-down assay showing the interaction of AP-2 core with mouse Arc(WT). Recombinant affinity purified
GST-AP-2 core [GST-tagged  subunit (residues 1– 621), 6xHis tagged 2 subunit (residues 1–591), full-length 2 and 2
subunits], was immobilized on glutathione beads (C, right) and incubated with recombinant affinity purified 6xHis-Arc(WT) (C, left).
Binding of Arc protein to GST-tagged AP-2 core or GST alone was analyzed by GST pull-down and SDS-PAGE, followed by
Coomassie blue staining (D, left) or immunoblot using an anti-Arc antibody (D, right). E, Schematic representation of the Arc-WT
sequence showing the truncated Arc mutants used in this study. The diagram indicates coiled-coil (CC) and spectrin repeat
homology (SRH) structure domain of mouse Arc. AP-2 binding site is shown in black. f, Pull-down assay showing the interaction
of AP-2 core with mouse Arc(WT) and the Arc(1-199) truncated (deletion of residues 200 –396). Recombinant affinity purified AP-2
core, was immobilized on glutathione beads and incubated with lysates of E. coli expressing Arc(WT) or Arc(1-199) deletion mutant.
Binding of Arc proteins to GST-tagged AP-2 or GST alone was analyzed by GST pull-down and SDS-PAGE, followed by
Coomassie blue staining (left) or immunoblot using an anti-His tag antibody (right). Ten percent of the recombinant proteins used
for the pull-down were loaded on the input lane (Bands corresponding to Arc proteins are indicated by white asterisks). G,
Pull-down assay showing that the Arc residues 195–199 are required for the Arc–AP-2 interaction as truncated Arc(1-194)
produced in E. coli lost the ability to bind immobilized recombinant GST-tagged AP-2 core.
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Figure 2. Identification of Arc motif that binds to AP-2. A, Pull-down assay showing that a conserved tryptophan residue at position
197 mediates Arc–AP-2 interaction. Recombinant GST-Arc(WT), GST-Arc(W197A), GST-Arc(195-199A), or GST alone were produced in E.
coli and immobilized on glutathione beads (bottom) and incubated with total brain tissue lysate. Binding of endogenous 2 and
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face, an effect that is impaired in cells expressing the
Arc(W197A), that cannot bind to AP-2 (Fig. 3C–G). Together,
these results indicate that Arc–AP-2 interaction is required
to facilitate AMPAR internalization.
The Arc–AP-2 interaction regulates AMPAR-
mediated synaptic currents
Previous findings have demonstrated that under basal
conditions hippocampal cultured neurons overexpressing
continued
-adaptins to GST fusion proteins was analyzed by SDS-PAGE immunoblotting with anti-2 (top) or anti- (middle) antibodies. Bar
chart plotting analysis of the relative amount of protein bound to GST and GST-Arc(W197A) and GST-Arc(195-199A) normalized to
GST-ArcWT (100%). B, Pull-down assay showing interaction of Arc(WT) and Arc(W197A) with dynamin 2. Recombinant GST-Arc(WT),
GST-Arc(W197A), or GST alone were produced in E. coli, immobilized on glutathione beads (bottom) and incubated with total lysates
of HEK293 cells expressing dynamin 2-GFP. Binding of dynamin 2-GFP to GST fusion proteins was analyzed by SDS-PAGE
immunoblotting with anti-GFP antibody (top). Bar chart plotting analysis of the relative amount of dynamin 2 bound on the beads
normalized to GST-ArcWT (100%). Ten percent of total protein lysate used to incubate the beads was used as input. C, Pull-down
assay showing interaction of Arc(WT), Arc(W197A), and GST-Arc(195-199A) with Triad3A. Recombinant GST proteins produced in E. coli
and immobilized on glutathione beads (bottom) were incubated with total lysates of HEK293 cells expressing GFP-Triad3A. Binding
of GFP-Triad3A to GST fusion proteins was analyzed by SDS-PAGE immunoblotting with anti-GFP antibody (top). Bar chart plotting
analysis of the relative amount of Triad3A bound on the beads normalized to GST-ArcWT (100%). Ten percent of total protein lysate
used to incubate the beads was used as input. Errors bars represent mean 	 SEM (n3 independent experiments). p0.05,
p0.005, and p0.0005 using unpaired Student´s t test.
Table 1. Statistical analyses
Results Data structure Type of test n numbers Probability, p
(Fig. 2A, top) IB pull-down  GST-Arc(WT) vs GST Two-factor, mean t test 3/3  0.0001
GST-Arc(WT) vs GST-Arc(W197A) Two-factor, mean t test 3/3  0.0001
GST-Arc(WT) vs GST-Arc(195-199A) Two-factor, mean t test 3/3  0.0001
(Fig. 2A, middle) IB pull-down 2 GST vs GST-Arc(WT) Two-factor, mean t test 3/3  0.0001
GST-Arc(WT) vs GST-Arc(W197A) Two-factor, mean t test 3/3 0.0007
GST-Arc(WT) vs GST-Arc(195-199A) Two-factor, mean t test 3/3 0.0039
(Fig. 2B) IB pull-down dyn2-GFP GST-Arc(WT) vs GST Two-factor, mean t test 3/3  0.0001
GST-Arc(WT) vs GST-Arc(W197A) Two-factor, mean t test 3/3 0.0159
(Fig. 2C) IB pull-down GFP-Triad3A GST-Arc(WT) vs GST Two-factor, mean t test 3/3  0.0001
GST-Arc(WT) vs GST-Arc(W197A) Two-factor, mean t test 3/3 0.0055
GST-Arc(WT) vs GST-Arc(195-199A) Two-factor, mean t test 3/3 0.0055
(Fig. 3A) IB Surface GluA1 pCIneo vs pArc(WT) Two-factor, mean ANOVA Tukey’s 3/3 0.1284
pCIneo vs pArc(W197A) Two-factor, mean ANOVA Tukey’s 4/4 0.5543
(Fig. 3B) IB Surface GluA2 pCIneo vs pArc(WT) Two-factor, mean ANOVA Tukey’s 4/4 0.9999
pCIneo vs pArc(W197A) Two-factor, mean ANOVA Tukey’s 4/4 0.9637
(Fig. 3B) IB Surface EGFR pCIneo vs pArc(WT) Two-factor, mean ANOVA Tukey’s 4/4 0.6156
pCIneo vs pArc(W197A) Two-factor, mean ANOVA Tukey’s 4/4 0.7621
(Fig. 3F) IF Surface GluA1 mCherry vs mCherry-Arc(WT) Two-factor, mean ANOVA Tukey’s 59/60 0.0001
mCherry vs mCherry-Arc(W197A) Two-factor, mean ANOVA Tukey’s 59/42 0.3438
(Fig. 3G) IF mCherry expression mCherry vs mCherry-Arc(WT) Two-factor, mean ANOVA Tukey’s 3/3 0.5625
mCherry vs mCherry-Arc(W197A) Two-factor, mean ANOVA Tukey’s 3/3 0.9211
(Fig. 3H) IB Arc expression mCherry-Arc(WT) vs mCherry- Arc(W197A) Two-factor, mean ANOVA Tukey’s 3/3 0.6892
mCherry-Arc(WT) vs mCherry- Arc(195-199A) Two-factor, mean ANOVA Tukey’s 3/3 0.4951
(Fig. 4) Arc–AP-2 interaction Arc(WT) vs untransfected amplitude frequency Two-factor, mean Mann–Whitney 12/20 0.0002 0.47
Arc(W197A) vs untransfected amplitude frequency Two-factor, mean Mann–Whitney 13/20 0.121 0.98
Arc(195-199A) vs untransfected amplitude frequency Two-factor, mean Mann–Whitney 10/20 0.372 0.18
eGFP vs untransfected amplitude frequency Two-factor, mean Mann–Whitney 7/20 0.376 0.39
(Fig. 5) cDNA constructs and mEPSC kinetics All constructs vs untransfected rise decay Two-factor, mean Mann–Whitney 6/18 0.05 0.05
(Fig. 6) AP-2 requirement for Arc mediated
changes in synaptic strength
2-miRNA2 vs untransfected amplitude
frequency
Two-factor, mean Mann–Whitney 9/12 0.07 0.37
Arc(WT)  2-miRNA2 vs untransfected
amplitude frequency
Two-factor, mean Mann–Whitney 16/12 0.52 0.63
Arc(WT)  n.c.miRNA vs untransfected
amplitude frequency
Two-factor, mean Mann–Whitney 7/12 0.001 0.08
2-miRNA3 vs untransfected amplitude frequency Two-factor, mean Mann–Whitney 10/8 0.68 0.45
Arc(WT)  2-miRNA3 vs untransfected
amplitude frequency
Two-factor, mean Mann–Whitney 6/8 0.27 0.14
(Fig. 7) The Arc-AP-2 interaction is required
for Arc-mediated changes in synaptic strength
Arc(WT) 2-miRNA22 vs untransfected
amplitude frequency
Two-factor, mean Mann–Whitney 14/14 0.0001 0.37
Arc(195-199A)2-miRNA22 vs untransfected
amplitude frequency
Two-factor, mean Mann–Whitney 9/14 0.46 0.64
(Fig. 8) AP-2 is required for homeostatic scaling Control vs bicuculline (untransfected)
amplitude frequency
Two-factor, mean Mann–Whitney 10/15 0.0001 0.64
miRNA2 (bicuculline) vs untransfected (bicuculline)
amplitude frequency
Two-factor, mean Mann–Whitney 6/15 0.0001 0.59
n.c.miRNA (bicuculline) vs untransfected
amplitude frequency
Two-factor, mean Mann–Whitney 5/15 0.007 0.29
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Figure 3. Arc–AP-2 interaction regulates GluA1 endocytosis. A, B, Representative blots showing that Arc(WT), but not the Arc(W197A)
mutant, facilitates GluA1, but not GluA2 endocytosis. H4 neuroglioma cells were transfected with plasmids encoding myc-GluA1 (A)
or myc-GluA2 (B) in combination with either: empty pCIneo vector, pCIneo Arc(WT), or pCIneo Arc(W197A). Western blot band
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Arc-WT have significantly less AMPAR on their surface
than neighboring untransfected neurons (Shepherd et al.,
2006). There is also a significant reduction in the ampli-
tude of AMPAR-mediated synaptic currents in CA1 neu-
rons overexpressing Arc-WT protein in hippocampal
slices (Rial Verde et al., 2006). Conversely, cultured hip-
pocampal neurons from Arc knock-out mice exhibit an
increased density of AMPAR at the cell surface and a
deficit in AMPAR endocytosis (Chowdhury et al., 2006).
Because Arc facilitates endocytosis of AMPAR and we
have demonstrated that Arc directly binds to the AP-2
complex, we predicted that the Arc–AP-2 interaction reg-
ulates expression of synaptic AMPAR. To test our predic-
tion, we first recorded AMPAR-mediated mEPSCs from
cultured hippocampal neurons overexpressing an Arc-
WT-GFP-tagged construct and from untransfected neigh-
boring cells in the same cultures. This approach was used
to negate any variations in AMPAR expression, which may
arise from differences in cell density. Recordings from
cells expressing EGFP alone were used as a control for
transfection. In agreement with previous studies, a signif-
icant decrease in mEPSC amplitude was observed in cells
overexpressing Arc(WT) compared with untransfected
neighboring cells (Fig. 4Ai; Rial Verde et al., 2006; Shep-
herd et al., 2006). Examination of the amplitude probabil-
ity curves from Figure 4a shows that the majority of
AMPAR-mediated mEPSCs had smaller amplitudes in the
cell where Arc(WT) was overexpressed (peak shifted to the
left, red trace) compared with the untransfected neighbor-
ing cell (black trace). In contrast, there was no significant
difference in the amplitude of mEPSCs recorded in an
eGFP-expressing cell and its untransfected neighbor (Fig.
4Bi; Table 1).
To test whether the Arc-mediated reduction in the AM-
PAR mEPSC amplitude is dependent on an interaction
with AP-2, we recorded mEPSCs from hippocampal cul-
tures overexpressing either Arc(195-199A)- or Arc(W197A)-
GFP-tagged mutant constructs. As predicted, the reduc-
tion in AMPAR-dependent mEPSC amplitudes observed
in cells overexpressing Arc(W197A) or Arc(195-199A) was sig-
nificantly less pronounced compared with cells overex-
pressing Arc(WT) (Fig. 4C,Di).Pooled data are displayed as
cumulative probability distributions (Fig. 4E) and as bar
charts plotting the mean amplitude and interval (Fig. 4F,G;
Table 1).
Our biochemical data show that Arc preferentially inter-
nalises GluA1 rather than GluA2 subunits (Fig. 3A,B). To
test whether Arc has similar effects on the endogenous
AMPA receptors, which are expressed at synapses, we
measured the rectification of AMPA receptor mediated
mEPSC amplitudes. The reduction in the surface expres-
sion of synaptic AMPA receptors containing GluA1 sub-
units would be expected to reduce rectification at positive
holding potentials (Bowie and Mayer, 1995; Kamboj et al.,
1995; Plant et al., 2006). As predicted, the rectification
index (calculated by dividing the amplitude of mEPSCs at
40 mV by the amplitude at 60 mV) was significantly
increased in cells expressing Arc(WT) compared with GFP-
and ArcW197A-expressing cells (Fig. 4H,I). Neither mEPSC
rise or decay kinetics were significantly effected by over-
expression of Arc(WT), Arc mutants, or eGFP (Fig. 5A–D).
The consistency in mEPSC rise and decay kinetics across
recordings (Fig. 5C,D; Table 1) demonstrates that any
changes in mEPSC amplitude are a result of receptor
internalisation rather than variations in recording quality.
These experiments suggest that the reduction in mEPSC
amplitude induced by Arc(WT) overexpression in hip-
pocampal neurons is dependent on the binding of Arc(WT)
to the AP-2 complex.
The AP2 subunit 2 is required for the
Arc(WT)-induced reduction in mEPSC amplitude
Previous studies have shown that depletion of the 2
subunit compromises the stability of the remaining sub-
units of AP-2 and also that the complexes lacking the 2
subunit are inactive and fail to localize to the plasma
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densitometry analysis showing that: (A) Arc(WT), but not Arc(W197A), promotes a significant reduction in surface expression of GluA1
subunits (control: 60.46 	 2.97%; Arc(WT): 38.55 	 7.44%; Arc(W197A): 50.18 	 8.34%. Error bars represent mean 	 SEM (n3
independent experiments). p0.05 using one-way ANOVA followed by Tukeýs post-test. B, Arc(WT) does not promote any changes
in surface expression of either GluA2 subunits (control: 132.9 	 26.66%; Arc(WT): 133.2 	 21,78%; Arc(W197A): 143.9 	 38.43%) or
EGF receptor (control: 51.35 	 10.43%; Arc(WT): 38.93 	 8.66%; Arc(W197A): 41.59 	 8.8%). Error bars represent mean 	 SEM (n4
independent experiments).Ten percent of the protein lysate used for incubate the beads was loaded in the input lane. GAPDH was
used as loading controls. C–F, C–G, H4 cells coexpressing myc-GluA1 with either mCherry construct alone (C), mCherry-Arc(WT) (D),
or mCherry-Arc(W197A) (E). Surface myc-GluA1 (non-permeabilized cells, green channel) was identified using mouse anti-myc antibody
followed by AlexaFluor 488 secondary antibody and internal myc-GluA1 (permeabilized, magenta channel) was identified by
polyclonal rabbit anti-myc antibody followed by AlexaFluor 647 secondary antibody. F, G, The mean florescence intensity (MFI) of
AlexaFluor 488 (surface my-GluA1) and mCherry (red channel) were calculated using confocal Z-projection images to quantify the
pixel intensity of surface myc-GluA1 and mCherry (total protein expression). F, Ratio of averaged MFI between surface (488)/total
protein (mCherry) for control cells (n59 cells) was set to 100% to facilitate comparison. Note that the ratio for surface GluA1 is
significantly reduced in cells expressing mCherry-Arc(WT) (34.68 	 3.13%; n 60 cells) compared with cells expressing mCherry
construct alone. Importantly, this reduction is absent in cells expressing the mCherry-Arc(W197A) construct (114.80 	 13.08%; n 42
cells. G, Bar chart plotting the averaged MFI expression levels of mCherry-Arc(WT) and mCherry-Arc(W197A) compared with mCherry
expression. Values are mean 	 SEM (n3 independent experiments). p0.05, p0.005 using one-way ANOVA followed by
Tukeýs post-test. Scale bar, 10 m. H, Representative blot and bar chart plotting bands densitometry analysis of Arc expression
protein in H4 cells transfected with equal amounts of mCherry-Arc(WT), mCherry-Arc(W197A), or mCherry-Arc(195-199A) plasmids. Note
the similar levels Arc protein expression between samples. Values are mean 	 SEM (n3 independent experiments).
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Figure 4. The Arc–AP-2 interaction regulates AMPAR-mediated synaptic currents. A–D, Representative live imaging of a
dissociated hippocampal neuron overexpressing Arc-GFP-tagged constructs and GFP. A, AMPAR-mediated mEPSC traces from a
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membrane (Meyer et al., 2000; Peden et al., 2002; Motley
et al., 2003). To further investigate the importance of the
Arc–AP-2 interaction, we designed shRNA-like se-
quences to knockdown the endogenous expression of 2
in mouse tissue. We then used these shRNA constructs to
transfect the mouse cell line NSC-34. A shRNA sequence,
not predicted to knockdown any vertebrate genes, was
used as a negative control. Using this approach, we
identified two out of three shRNA sequences (2-shRNA2
and 2-shRNA3) that efficiently reduced the protein ex-
pression of 2 in NSC-34 cells (Fig. 6A). To knockdown
endogenous 2 in neurons, we generated lentiviruses
expressing these two shRNAs. The lentiviruses also ex-
press emGFP isocistronically, to efficiently identify the
transduced neurons. Lentiviral transduction of 2-
shRNA2 into hippocampal cultures resulted in an overall
50% reduction in 2 expression compared with the neg-
ative control shRNA (Fig. 6B). Note that even under opti-
mal circumstances transduction rates in primary neurons
are between 70% and 80% using lentiviral systems. This
indicates that a significantly more pronounced reduction
in 2 expression has been achieved in those cells that
have been transduced and used for recordings. To
examine whether AP-2 is required in AMPAR-mediated
synaptic transmission under basal conditions, we first
transduced hippocampal cultures at 6–7 DIV with a len-
tivirus expressing 2-shRNA2-emGFP and recorded
AMPAR-mediated mEPSCs 7–8 d after transfection. No
significant change in mEPSC amplitude was observed in
cells expressing 2-shRNA2 alone compared with un-
transfected neighboring cells (Fig. 6Ci). These findings
suggest that the constitutive endocytosis of AMPAR oc-
curring under basal conditions in cultured hippocampal
neurons is not strictly dependent on AP-2.
To test whether AP-2 is required for Arc-mediated
endocytosis of AMPAR, we recorded mEPSCs from
hippocampal neurons expressing either 2-shRNA2-
emGFP- plus mCherry-Arc-WT or the negative control
(n.c.) shRNA-emGFP plus mCherry-Arc-WT, as well as
untransfected neighboring neurons. Consistent with our
hypothesis, a 30% reduction in mEPSC amplitudes was
seen in neurons expressing Arc(WT) plus n.c. shRNA (Fig.
6Di). However, this reduction in mEPSC amplitude was
abolished in cells coexpressing Arc-WT plus 2-shRNA2
(Fig. 6Ei). Pooled data are displayed as cumulative prob-
ability distributions (Fig. 6F) and as bar charts plotting the
mean amplitude and interval (Fig. 6G,H; Table 1). To
confirm this observation, we also recorded AMPAR-
mediated mEPSCs from neurons expressing either 2-
shRNA3 alone or together with Arc-WT. Again, no change
in mEPSC amplitudes was seen in cells expressing 2-
shRNA3 alone (Fig. 6I,J). However, expression of 2-
shRNA3 blocked the Arc-WT-mediated decrease in
mEPSC amplitudes (Fig. 6I–K). Neither mEPSC rise or
decay kinetics was significantly affected by overexpres-
sion of either 2-shRNA2 or 2-shRNA3 alone, Arc-WT
plus 2-shRNA2 or, 2-shRNA3, or Arc(WT) plus n.c.
shRNA (Fig. 5). These results demonstrate that knock-
down of the AP-2 complex is sufficient to disrupt the
Arc-mediated endocytosis of AMPAR. Together, these
findings suggest that AP-2 is required for the Arc-
mediated endocytosis of AMPAR in hippocampal neu-
rons.
Arc-mediated reduction in AMPAR-mediated mEPSC
amplitude requires the binding of Arc to AP-2
We have shown that: (1) the reduction in AMPAR-
mediated mEPSC amplitude observed in neurons overex-
continued
neuron overexpressing Arc(WT) and an untransfected neighboring neuron. Ai, Amplitude probability distribution for the mEPSCs shown
in A. Note the shift to the left and increase in the amplitude of the main peak in the neuron overexpressing Arc(WT), clearly
demonstrating the reduction in mEPSC amplitude. Inset, Superimposed average mEPSC waveforms. B, Representative AMPAR-
mediated mEPSC traces from a neuron overexpressing GFP and an untransfected neighboring neuron. Bi, Amplitude probability
distributions for mEPSCs recorded from the neurons shown in B. Inset, Superimposed average mEPSC waveforms. C, Representative
AMPAR-mediated mEPSC traces from a neuron expressing Arc(W197A) and an untransfected neighboring neuron. Ci, Amplitude
probability distributions from neurons shown in C. Note that expression of Arc(W197A) produced a smaller reduction in mEPSC
amplitude compared with Arc(WT) overexpression. Inset, Superimposed average mEPSC waveforms. D, Representative AMPAR-
mediated mEPSC traces from a neuron expressing Arc(195-199A) and an untransfected neighboring neuron. Di, Amplitude probability
distributions from neurons shown in d. Note that expression of Arc(195-199A), in which the sequence 195QSWGP199 of Arc was
mutated to 195AAAAA199 had little effect on mEPSC amplitude. Inset, Superimposed average mEPSC waveforms. E, Cumulative
probability distributions for cells expressing Arc(WT) (12 neurons), Arc(W197A) (13 neurons), Arc(195-199A) (10 neurons), GFP (7 neurons),
and for untransfected cells (20 neurons). F, Bar chart plotting mean mEPSC amplitude for the cells in E. Expression of Arc(WT)
significantly reduced mEPSC amplitude (mean reduced from 15.99 	 0.9 pA in untransfected cells to 10.56 	 0.66 pA, p 0.0002),
whereas expression of Arc(W197A) or Arc(195-199A) had no significant effect (14.6 	 0.74 pA, p0.12 and 14.01 	 1.2 pA, p 0.37).
Expression of eGFP had no significant effect (p0.376) on the mean mEPSC amplitude compared to untransfected cells. G, Bar chart
plotting the mean interval between mEPSCs. Expression of Arc(WT) and the Arc mutants had no significant effect on the frequency of
mEPSCs. Although the mean frequency of mEPSCs in cells expression Arc(WT) appeared reduced, this was not significant as there
was large variability between cells. H, Representative average mEPSC waveforms recorded at a holding potential of 60 and  40
mV for cells expressing GFP, Arc(WT), and Arc(W197A) in the presence of spermine (100 M) in the intracellular solution. I, Bar chart
plotting the mean rectification index (peak amplitude at 40 mV divided by peak amplitude at 60 mV) for neurons expressing GFP
(n  9 cells; 0.34 	 0.015), Arc(WT) (n  9 cells; 0.62 	 0.016), and Arc(W197A) (n  6 cells; 0.45 	 0.015). Thus, Arc(WT) reduces the
amount of rectification (as seen as an increase in the rectification index), whereas Arc(W197A) has significantly less effect on
rectification. Error bars in F, G, and I are SEM. p0.001, p0.01. Statistical significance was tested using the Mann–Whitney
test. Scale bar, 10 m.
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pressing Arc(WT) is either reduced or abolished in neurons
expressing mutated Arc, which cannot bind to AP-2 (Fig.
4); and (2) that the effect of Arc-WT overexpression on
mEPSC amplitude is reduced in neurons expressing a
decreased amount of AP-22 protein (Fig. 6). These data
suggest that Arc requires AP-2 to facilitate the internal-
ization of AMPAR. To confirm the functional relationship
between Arc and AP-2, we recorded mEPSCs from hip-
pocampal neurons expressing Arc-WT and 2-shRNA2-
emGFP in the same lentivirus combined with re-
expression of 2 using another lentivirus expressing a
2-shRNA2 resistant 2-mCherry fusion protein. As a
control, lentiviruses encoding Arc(195-199A)/2-shRNA2-
emGFP and 2-mCherry was used to transduce hip-
pocampal cultures. As predicted, the Arc(WT)-mediated
reduction in AMPAR mEPSC amplitude caused by deple-
tion of AP-2/2 (Fig. 4) was reversed by overexpressing
2 (Fig. 7Ai), demonstrating that AP-2/2 is specifically
required for the effect of Arc on AMPAR amplitudes. In
contrast, no effect on AMPAR amplitudes was seen in
cells expressing a mutant form of Arc(195-199A) that cannot
bind to AP-2, irrespective of the expression status of 2
(Fig. 7Bi,C). Pooled data are displayed as cumulative
probability distributions (Fig. 7C) and as bar charts plot-
ting the mean amplitude and interval (Fig. 7D,E; Table 1).
Neither mEPSC rise or decay kinetics were significantly
affected by overexpression of Arc-WT-2-shRNA2-
emGFP plus 2-mCherry and Arc(195-199A)-2-shRNA2-
emGFP plus 2-mCherry (Fig. 5). These experiments
clearly demonstrate that the Arc–AP-2 interaction is re-
quired for the reduction in AMPAR-mediated mEPSC am-
plitudes rather than sole disruption in AP-2.
AP-2 is required for Arc-dependent homeostatic
scaling
Homeostatic scaling is the ability of neurons to sense the
level of synaptic activity and compensate for changes by
modulating their excitability. For example, in response to
a prolonged increase in synaptic activity, neurons reduce
synaptic strength by facilitating endocytosis of synaptic
AMPAR (downscaling). Arc, whose expression is robustly
induced by increased activity, is known to facilitate syn-
aptic downscaling by enhancing AMPAR endocytosis
(Shepherd et al., 2006; Mabb et al., 2014). Because we
have shown that AP-2 is required for the Arc-dependent
endocytosis of AMPAR, we hypothesized that a reduction
in AP-2 expression should impair Arc-dependent synaptic
scaling. To test this, we recorded AMPAR-mediated mEP-
SCs from hippocampal, cultured neurons chronically
treated with bicuculline (40 M, 48 h), which blocks inhib-
itory neurotransmission mediated by GABAA receptors
and thus increases neuronal firing. In agreement with
previous studies (Shepherd et al., 2006; Mabb et al.,
2014), we observed a significant decrease in the ampli-
tude of AMPAR-dependent mEPSCs in cells incubated
with bicuculline compared with control cells (Fig. 8A–C).
To address whether AP-2 was required for this reduction
in mEPSC amplitude, we reduced 2 expression by trans-
ducing hippocampal neurons with 2-shRNA2, and as a
control, n.c. shRNA, for 5 d prior to bicuculline incubation.
Figure 5. Overexpression of Arc-cDNAs does not affect
AMPAR-mediated mEPSC kinetics in hippocampal neurons.
A, Average of 75 mEPSCs aligned on the midpoint of the rising
phase) from an individual neuron expressing Arc(WT). The decay
was fitted with a single exponential ( 4.5 ms, black line). Inset,
The average mEPSC at an expanded time base showing the
exponential fit to the decay. B, Average of 80 mEPSCs (aligned
on the midpoint of the rising phase) from an untransfected
neuron which was a close neighbor to the cell in A. The decay of
the mEPSC was very similar to the transfected neighbor (the
decay was fitted with a single exponential;   4.7 ms, black
line). Inset, The average mEPSC at an expanded time-base to
show the exponential fit to the decay. C, Bar chart plotting the
mean 10–90% rise time of mEPSCs recorded from untrans-
fected neurons (n 18) and from neurons expressing different
constructs and in different conditions (n  6 for each). The mean
rise time was calculated by averaging the rise time of mean
currents from individual recordings. There was no significant
difference in the mean mEPSC rise time recorded from any of the
neurons. D, Bar chart plotting the mean decay time constant ()
from untransfected neurons (n18) and from neurons express-
ing different constructs and in different conditions (n6 for
each). The mean decay time constant () was calculated by
averaging the time constant from the decay of mean currents
from individual recordings. The decay of mEPSCs was not sig-
nificantly different between conditions. The error bars in C and D
are SEM. Statistical significance was tested using the Mann–
Whitney test
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Figure 6. AP-2 is required for Arc-dependent changes in synaptic strength. A, Blots showing levels of 2 protein obtained from
NSC cells overexpressing n.c. shRNA, 2-shRNA2, 2-shRNA3 plasmids for 3–4 d. GAPDH was used as loading control. Bar chart
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In neurons expressing the n.c. shRNA, bicuculline incu-
bation still resulted in a robust reduction in mEPSC am-
plitude (Fig. 8B,C). However, the reduction in mEPSC
amplitude was significantly smaller in neurons expressing
2-shRNA2 (Fig. 8A–C). None of the treatments signifi-
cantly (p0.05) changed the frequency of mEPSCs (Fig.
8D; Table 1) or the rise or decay kinetics of mEPSCs (Fig.
5). Together, these findings support the hypothesis that
the Arc–AP-2 interaction is required for the endocytosis of
AMPAR during homeostatic scaling.
Discussion
The present study identifies a functional link between Arc
and the AP-2 complex, a vital component of CME path-
way. The AP-2 complex is required for selection and
recruitment of the endocytic cargo and also for clathrin
recruitment to the plasma membrane, processes that ini-
tiate the formation of the clathrin-coated pit (Robinson,
2004; Saheki and De Camilli, 2012; Kelly et al., 2014;
Kirchhausen et al., 2014). Here, we demonstrate that Arc
immunoprecipitates with the AP-2 complex in hippocam-
pal lysate and that Arc directly binds to the AP-2 complex
(Fig. 1). We also show that the Arc residues 195QSWGP199
mediate the Arc–AP-2 association and that a conserved
tryptophan residue at position 197 (W197) is essential for
this interaction (Fig. 2). Importantly, the GST-Arc mutants
that are impaired in AP-2 binding still bound to another
binding partner, Triad3A, demonstrating the structural in-
tegrity of the mutated Arc proteins. Interestingly, the mu-
tated Arc proteins pulled down higher levels of Triad3A
compared with GST-Arc(WT) from cell extracts (Fig. 2).
Although the reasons for these results were not ad-
dressed here, one possible explanation is that preventing
the AP-2 interaction may render Arc’s C-terminal domain
more accessible to make contacts with Triad3A, leading
to increased binding. Importantly, this apparently higher
affinity for the ubiquitin ligase Triad3A does not cause
changes in the expression/stability of the Arc mutants
(Fig. 3). This further demonstrates that the observed func-
tional changes of the Arc mutants are specifically due to
the loss of its binding to AP-2. In agreement with previous
studies (Shepherd et al., 2006; Waung et al., 2008), we
showed that overexpression of Arc strongly reduces sur-
face expression of GluA1, but not GluA2 in H4 neurogli-
oma cells (Fig. 3). In cultured hippocampal neurons,
overexpression of Arc reduces the number of synaptic
AMPA receptors, as shown by a decrease in the ampli-
tude of AMPAR-mediated mEPSCs and also regulates
AMPA receptor subunit composition (Fig. 4). It was pre-
viously shown that AMPAR containing GluA2 subunits
show a linear current–voltage relationship in contrast to
GluA2-lacking receptors that show pronounced rectifica-
tion (Isaac et al., 2007). In our experiments, mEPSCs
recorded from neurons overexpressing GFP alone
showed pronounced rectification, suggesting that the
predominant combination of AMPA receptors lacks the
GluA2 subunit (Eales et al., 2014). In contrast, overexpres-
sion of Arc resulted in diminished mEPSCs rectification,
suggesting a reduction in the proportion of synaptic re-
ceptors that lack the GluA2 subunit. These findings are in
agreement with previous studies showing that there is an
increase in surface expression of GluA1, but not GluA2
subunits in hippocampal cultures obtained from Arc
knock-out mice at non-stimulated conditions (Shepherd
et al., 2006). Also knock-down of endogenous Arc in
hippocampal cultures resulted in increased GluA1 sub-
units at the surface at non-stimulated conditions (Waung
et al., 2008). Furthermore, application of DHPG (which
induces an increase in Arc translation and protein expres-
continued
plotting the analysis of 2 band intensity normalized by GAPDH. Error bars indicate 	 SEM and significance was tested using
one-way ANOVA. p0.0001. B, Blots showing levels of 2 protein obtained from cultured hippocampal neurons infected for 8–9
d with lentiviruses expressing either 2-nc shRNA or 2-shRNA2 sequences for 8–9 d. GAPDH was used as loading control. Bar chart
plotting the analysis of 2 band intensity normalized by GAPDH intensity. Error bars indicate	 SEM and significance was tested using
one-way ANOVA. p0.019. C, Representative AMPAR-mediated mEPSC traces from a neuron expressing 2-shRNA2 and an
untransfected neighbor. Ci, Amplitude probability distributions from the neuron shown in C. Note that reduction of AP-2 expression
(2-shRNA2) has little effect on mEPSC amplitude. Inset, superimposed average mEPSC waveforms. D, Representative AMPAR-
mediated mEPSC traces from a neuron coexpressing Arc(WT) and nc shRNA and an untransfected neighbor. Di, Amplitude probability
distribution from the neurons in D. Note that coexpression of a n.c. shRNA does not prevent overexpression of Arc from reducing
mEPSC amplitude. Inset, Superimposed average mEPSC waveforms. E, Representative AMPAR-mediated mEPSC traces from a
neuron coexpressing Arc(WT) and 2-shRNA2 and an untransfected neighbor. Ei, Amplitude probability distribution from the neurons
showed in E. Note that coexpression of 2-shRNA2 prevents the effects of Arc(WT) on mEPSC amplitude. Inset, Superimposed
average mEPSC waveforms. F, Cumulative probability distributions for cells expressing shRNA2 (9 neurons), Arc(WT)  shRNA2 (16
neurons), Arc(WT)n.c shRNA (7 neurons), and for untransfected cells (12 neurons). G, Bar chart plotting mean mEPSC amplitude for
the cells in f. Expression of shRNA2 prevented the Arc(WT) overexpression effect of significantly reducing mEPSC amplitude (mean
mEPSC amplitude 15.3 	 1 pA in untransfected cells, Arc(WT)  shRNA2 14.3 	 0.8 pA; p0.52). Expression of shRNA2 alone had
no significant effect on mEPSC amplitude (13 	 0.7 pA; p0.07), whereas Arc(WT)  n.c. shRNA significantly reduced mEPSC
amplitude (10.2 	 0.53 pA; p0.001). H, Bar chart plotting the mean interval between mEPSCs for the cells in F. The error bars in
G and H are SEM. p0.001, p0.005. Statistical significance was tested using the Mann–Whitney test. I, Amplitude probability
distributions for a neuron expressing 2-shRNA3 and an untransfected neighbor and for a neuron overexpressing Arc(WT) with
2-shRNA3 and an untransfected neighbor (J). Inset, Superimposed average mEPSC waveforms. K, Bar chart of mean mEPSC
amplitudes for untransfected cells (n  8), cells transfected with 2-shRNA3 (n10) and cells transfected with Arc(WT) 2-shRNA3
(n6). Neither expression of 2-shRNA3 or Arc(WT)2-shRNA3 significantly changed mEPSC amplitude (p0.68 and p0.27,
respectively).
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sion) to cultured hippocampal neurons reduced rectifica-
tion (Eales et al., 2014). As expected, mutation of the AP-2
binding site in Arc or depletion of AP-22 compromises
the capacity of Arc to reduce AMPAR-mediated mEPSC
amplitudes (Figs. 4–6). Furthermore, the Arc-mediated
reduction in AMPAR mEPSC amplitudes was rescued in
cells where depletion of AP-22 was reversed by reintro-
ducing 2 (Fig. 7). Importantly, this rescue was compro-
Figure 7. Arc–AP-2 interaction is required for the Arc-mediated reduction in AMPAR mEPSC amplitude. A, Representative
AMPAR-mediated mEPSC traces from a neuron expressing Arc(WT)2-shRNA22 and an untransfected neighboring neuron. Ai,
Amplitude probability distributions from the neurons showed in A. Note that reintroduction of 2 rescued the effect of Arc(WT)
overexpression leading to a reduction in the amplitude of mEPSC amplitudes (shift to the left, red trace). Inset, Superimposed average
mEPSC waveforms. B, Representative AMPAR-mediated mEPSC traces from a neuron expressing Arc(195-199A)2-shRNA22 and
an untransfected neighboring neuron. Bi, Amplitude probability distributions from the neurons showed in D. Note that reintroduction
of 2 has little effect in mEPSC amplitude (no shifts between black and red traces). Inset, Superimposed average mEPSC waveforms.
C, Cumulative probability distributions for cells expressing Arc(WT) 2-shRNA2 2 (14 neurons), Arc(195-199A) 2-shRNA2 2 (9
neurons), and untransfected cells (14 neurons). D, Bar chart plotting mean mEPSC amplitude for the cells in C. Expression of 2
rescued the reduction in mEPSC amplitude produced by Arc(WT) overexpression, following the knockdown of AP-2 by shRNA2 (mean
mEPSC amplitude in untransfected cells 16.9 	 1.3 pA vs 10.1 	 0.6 pA in cells expressing Arc(WT) 2-shRNA2 2; p0.0001).
In contrast, expression of 2 had no significant effect on mEPSC amplitude when Arc(195-199A), which does not interact with AP2, was
expressed together with shRNA2 (15.9 	 1.7 pA; p  0.46). E, Bar chart plotting the mean interval between mEPSCs for the cells in
C. The error bars in D and E are SEM. p0.001, p0.01. Statistical significance was tested using the Mann–Whitney test.
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mised in cells expressing a mutated form of Arc that
cannot interact with AP-2 (Fig. 7). Furthermore, disruption
of the Arc–AP-2 interaction by reducing the expression of
AP-22 also dampens the Arc-mediated reduction in syn-
aptic strength observed in homeostatic synaptic down-
scaling (Fig. 8). Combined, these experiments
demonstrate that Arc-dependent endocytosis of AMPARs
requires an interaction of Arc with AP-2. It has been
recently shown that dynamin activity is not required to
reduce AMPA receptors surface levels induced by expo-
sure to bicuculline and potassium chloride, suggesting
that homeostatic downscaling may also be induced in a
clathrin-independent manner (Glebov et al., 2015). Thus,
we cannot discard the possibility that AMPA receptor
endocytosis via an as yet non-identified clathrin/dynamin
independent mechanism may contribute to regulate syn-
aptic strength seen in homeostatic synaptic downscaling.
The requirement of Arc regulating synaptic plasticity in
the hippocampus is well established (Rial Verde et al.,
2006; Bramham et al., 2010; Jakkamsetti et al., 2013;
Mabb et al., 2014). However, to utilize Arc as a potential
therapeutic target, it would be beneficial to obtain its
crystal structure. During the development of this project,
no information on Arc structure was available. As we have
discovered that the interaction between Arc and AP-2
depends on a short motif in the Arc sequence (195–199),
we have undertaken homology modelling studies using
the iTASSER suite (http://zhanglab.ccmb.med.umich.
edu/I-TASSER; Roy et al., 2010) to investigate the struc-
tural properties of this region and to obtain clues as to the
structural nature of the interaction interface. Unfortu-
nately, we were not able to obtain a model with a reason-
able confidence score. The main reason for this is that
there are no other protein structures in the databank that
Figure 8. AP-2 is required for Arc-dependent homeostatic scaling. A, Average mEPSC waveforms from an untransfected neuron
cultured in control conditions, from an untransfected neuron exposed to bicuculline and from a 2-shRNA2 expressing neuron that
has been incubated in bicuculline (40 M; 48 h). Note that the bicuculline-induced down regulation of the mEPSC amplitude was
reduced in AP-2 depleted cells (2-shRNA2 expressing cells).The untransfected neuron and the neuron expressing 2-shRNA2 that
were cultured in the presence of bicuculline were neighbors in the same dish, while the untransfected neuron cultured in control
conditions was from the same preparation. B, Cumulative amplitude distribution for untransfected neurons cultured in control
conditions (black line, n10 neurons), untransfected neurons incubated in bicuculline (red line, n15 neurons), 2-shRNA2
expressing cells incubated in bicuculline (blue line; n6 neurons) and cells transfected with n.c. shRNA incubated in bicuculline (green
line; n5 neurons). C, Bar chart plotting the mean mEPSC amplitude for the cells shown in B. Incubation in bicuculline significantly
reduced the mean mEPSC amplitude (from 17.3 	 1 pA to 11.9 	 0.2 pA; p0.0001). Expression of shRNA2 significantly increased
mEPSC amplitude in bicuculline (14.38 	 0.16 pA; p0.0001), whereas n.c shRNA had significantly less effect (12.9 	 0.28 pA;
p0.007). D, Bar chart plotting the mean interval between mEPSCs for the cells in B and C. The error bars in C and D are SEM.
p0.001, p0.01. Statistical significance was tested using the Mann–Whitney test.
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are sufficiently related to Arc to allow modelling by ho-
mology approaches. Our attempts are in agreement with
a recent study (Myrum et al., 2015) that also obtained
models with low scores that were deemed to be only
moderately reliable. In addition, the central region of the
protein was suggested to be largely unstructured and
flexible and the area containing the AP-2 interaction motif
described in this study was not included in the models.
Interestingly, another recent study (Zhang et al., 2015) has
succeeded in obtaining a partial crystal structure of Arc,
demonstrating that the C-terminal part of Arc is evolution-
ary similar to the Ty3/Gypsy retrotransposon and that it
shows similarity to the HIV gag protein. However, the
crystal obtained does not include the N-terminal se-
quences up to amino acid 206 and therefore does not
include the AP-2 binding motif. Nevertheless, as both
studies (and our own modelling approach) suggested that
the AP-2 binding motif is in a flexible and at least partly
unstructured region of the protein, it is highly likely that
this region of Arc is able to serve as a binding platform for
multiple partners, including AP-2.
Arc has been shown to mediate endocytosis of AMPAR
via interaction with dynamin 2 and endophilin 3, which are
accessory proteins of the CME machinery (Chowdhury
et al., 2006). Endophilin and dynamin are required for
membrane constriction and scission of the CCV, which
are late events in the CME process. Recent evidence,
using mature cultured cortical neurons from distinct
knock-out mice where specific endophilins have been
knocked out, clearly demonstrated that the assembly and
early maturation events of clathrin-coated pit formation
are independent of endophilin (Milosevic et al., 2011).
Dynamin is recruited at late stages of endocytosis and its
enrichment coincides with neck fission and release of the
vesicle (Ferguson and De Camilli, 2012; Grassart et al.,
2014). These findings clearly demonstrate that endophilin
and dynamin do not participate in the cargo selection
process. In contrast, AP-2 plays a critical role in the
initiation of clathrin-mediated endocytosis, as it coordi-
nates the cargo recruitment and selection together with
clathrin recruitment and lattice assembly (Robinson,
2004; Kelly et al., 2014; Kirchhausen et al., 2014). The
AP-2 complex is thought to exist in an inactive “closed”
conformation in the cytosol that prevents unproductive
interaction with clathrin. Binding to plasma membrane
enriched phosphatidylinositol-4,5-bisphosphate [PtdIns
(4,5)P2] and to transmembrane cargo, triggers conforma-
tional changes in AP-2 that are necessary to allow effi-
Figure 9. Arc–AP-2 interaction controls synaptic strength. The proposed model showing the mechanism by which Arc–AP-2
interaction facilitates AMPAR endocytosis. An increase in neuronal activity promotes rapid Arc mRNA translation and protein
expression at the dendritic spines. 1, Newly expressed Arc binds to the AP-2 complex and may activate/facilitate AP-2 interaction with
AMPAR at the plasma membrane. 2, To initiate the formation of the clathrin-coated assembly AP-2 binds and recruits clathrin to the
membrane. 3, 4, Arc then binds and recruits endophilin and dynamin to promote scission of the endocytic vesicle containing the
AMPAR to be targeted for either recycling or degradation.
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cient binding to clathrin and bud formation which is
thought to be the dominant mechanism for the initiation of
clathrin coat assembly (Kelly et al., 2014). The current
model, in which Arc is able to induce clathrin-mediated
AMPAR endocytosis via interaction with endophilin and
dynamin, does not place Arc as a decisive player in
specifically controlling excitatory synaptic transmission.
Importantly, our finding that Arc directly binds to AP-2
provides the mechanistic link by which activity-dependent
expression of Arc specifically facilitates endocytosis of
AMPAR. We therefore suggest a refined model where
neuronal excitability induces an increase in Arc protein
expression in dendritic spines (Fig. 9). Newly expressed
Arc then interacts with AP-2 and possibly increases its
affinity for the cytosolic tail of AMPA receptors. Activated
AP-2 initiates the formation of the clathrin-mediated pits
(CMPs) by coordinating the assembly of clathrin and bind-
ing to AMPAR at the postsynaptic density. We speculate
that following the formation of CMP, Arc then binds and
recruits endophilin and dynamin, which trigger fission of
the vesicle neck. Arc may not be able to simultaneously
bind to AP-2 and endophilin/dynamin. Therefore, one
possible explanation is that following CMP formation, the
affinity between Arc and AP-2 is reduced, releasing Arc
from the CMP. The unbound Arc then binds and recruits
endophilin and dynamin, which promotes neck fission and
release of the CCV. Alternatively, Arc binding to dynamin/
endophilin may be facilitated through AP-2 interacting
partners, such as amphiphysin, which is able to bind to
both AP-2 and dynamin (Slepnev et al., 2000). In fact,
AP-2 has been described as a major hub for recruitment
of accessory proteins to the maturing CMP (Schmid et al.,
2006; McMahon and Boucrot, 2011). Our discovery that
Arc directly binds to AP-2, which in turn regulates AMPAR
endocytosis, provides the crucial mechanistic link ex-
plaining how activity-dependent expression of Arc regu-
lates synaptic plasticity and therefore plays a critical role
in learning and memory formation.
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